Luchetti et al. found that the release of sEVs from a CRC cell line could promote cancer cell migration through the enhanced phosphorylation of signalling molecules, such as SRC and ERK, with a subsequent activation of the MAPK signalling cascade [13]. The gene discussed is MAPK1; the disease is colorectal carcinoma.